# Endonovo Therapeutics, Inc. – FDA Inspection, Oct 31, 2025

Source: https://www.keypedia.com/records/fda_inspections/endonovo-therapeutics-inc/d4a5098f-5a68-453f-9404-7e0705957b33
Source feed: FDA_Inspections

> FDA inspection 1289500 of Endonovo Therapeutics, Inc., October 31, 2025. Classification: No Action Indicated (NAI). 2 citations under 21 CFR part 820. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1289500
- Company Name: Endonovo Therapeutics, Inc.
- Inspection Date: 2025-10-31
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: Los Angeles District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1181508 - 2022-10-13
- FDA Inspection 1093798 - 2019-05-14

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sarah-a-hassas/4f142d54-fc28-4bd5-82ad-7e6fa443688c)

Company: https://www.keypedia.com/companies/endonovo-therapeutics-inc/819d1466-398f-4ac9-87a8-052819520724

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
